Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Submission of Investor Presentation that would be used in the investors/analyst call on unaudited financial results of the Company for the first quarter ended June 30,2025